SERUM FREE LIGHT CHAINS (SFLC) ASSAY: A SUGGESTIVE NEW CRITERIA FOR EVALUATING DISEASE RESPONSE, PROGRESSION AND RELAPSE IN PLASMA-CELL DISORDERS (PD) AND A PROGNOSTIC FACTOR IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)